Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.65    -0.10 (-5.71%)
Bid:
1.50
Ask:
1.80
Spread: 0.30 (20.00%)
Market Cap: £270.77k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Director Appointment

20 Feb 2023 07:49

RNS Number : 4155Q
Iconic Labs PLC
20 February 2023
 

20 February 2023

 

Iconic Labs PLC

("Iconic" or the "Company")

Director Appointment

 

Iconic Labs PLC (LSE:ICON), is pleased to announce that Emmanuel Blouin has been appointed to the Board of Directors with immediate effect.

Mr. Blouin has 25 years of investment and banking experience. He was a senior banker with Morgan Stanley, JP Morgan and BNP Paribas, during which he was involved in over €50 billion of capital markets, corporate finance and property transactions across Europe. In 2008, Mr. Blouin established Esterel Capital, a London-based boutique focusing on real estate and finance, where he continues to be Managing Partner.

Mr. Blouin is also currently a director of Courbet SA, a hospitality investment company listed on the Paris Stock Exchange, as well as an Independent Non-Executive Director of Aradei Capital, a commercial property investment and management company listed on the Casablanca Stock Exchange.

The following information is disclosed about Mr. Emmanuel Blouin:

Current Directorships / Partnerships

Aradei Capital

Courbet SA

Esterel Capital LLP

Stanrock Capital Ltd

Squareconcept Property Management Ltd

Previous Directorships / Partnerships held in the past 5 years: None

Brad Taylor, CEO of Iconic Labs, commented:

"I welcome Emmanuel to the Iconic board of directors. He is a highly skilled professional with significant expertise in corporate finance and international dealmaking. This experience, coupled with his vast network, will serve Iconic and its shareholders well as the company develops and implements an acquisition and growth strategy. With Iconic directors now in the United States, United Kingdom, and Europe, we are well-positioned to maximize our potential for value creation."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

- ENDS -

 

For any further information or enquiries please contact:

 

ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBLBLXLLZBBK
Date   Source Headline
29th Apr 201910:14 amRNSTR1 Align Research
26th Apr 201911:05 amRNSHolding(s) in Company
26th Apr 201911:00 amRNSHolding(s) in Company
25th Apr 201910:30 amRNSUpdate on Option
23rd Apr 201911:30 amRNSHolding(s) in Company
17th Apr 201910:05 amRNSHolding(s) in Company
17th Apr 201910:00 amRNSHolding(s) in Company
16th Apr 201912:45 pmRNSHolding(s) in Company
12th Apr 201911:35 amRNSDirector's Interest
12th Apr 201911:30 amRNSHolding(s) in Company
8th Apr 201910:10 amRNSHolding(s) in Company
5th Apr 201912:15 pmRNSHolding(s) in Company
5th Apr 201912:10 pmRNSHolding(s) in Company
3rd Apr 20195:37 pmRNSHolding(s) in Company
2nd Apr 201910:15 amRNSUpdate
21st Mar 20195:02 pmRNSHolding(s) in Company
21st Mar 20195:01 pmRNSUpdate
21st Mar 20195:00 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSOne2One Investor Forum
19th Mar 20191:42 pmRNSHolding(s) in Company
19th Mar 20191:41 pmRNSHolding(s) in Company
18th Mar 20192:05 pmRNSSecond Price Monitoring Extn
18th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201911:45 amRNSHolding(s) in Company
18th Mar 20199:05 amRNSSecond Price Monitoring Extn
18th Mar 20199:00 amRNSPrice Monitoring Extension
18th Mar 20197:00 amRNSNew Media Business Created
14th Mar 201910:47 amRNSHolding(s) in Company
14th Mar 201910:46 amRNSUpdate
14th Mar 201910:45 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSHolding(s) in Company
11th Mar 20198:48 amRNSHolding(s) in Company
8th Mar 20194:48 pmRNSHolding(s) in Company
8th Mar 20194:47 pmRNSUpdate
8th Mar 20194:46 pmRNSHolding(s) in Company
8th Mar 20194:45 pmRNSHolding(s) in Company
7th Mar 20192:05 pmRNSSecond Price Monitoring Extn
7th Mar 20192:00 pmRNSPrice Monitoring Extension
7th Mar 201911:00 amRNSPrice Monitoring Extension
6th Mar 20194:03 pmRNSUpdate
6th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 201911:05 amRNSSecond Price Monitoring Extn
5th Mar 201911:00 amRNSPrice Monitoring Extension
28th Feb 20192:20 pmRNSHolding(s) in Company
26th Feb 20195:44 pmRNSHolding(s) in Company
25th Feb 20198:12 amRNSDirectorate Change
22nd Feb 20195:50 pmRNSPublication of Prospectus
20th Feb 20194:06 pmRNSHolding(s) in Company
1st Feb 201912:35 pmRNSHolding(s) in Company
24th Jan 20193:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.